Purchase Order 36C24420P0670
Award Date 7/14/20
Potential Completion Date 5/15/21
Potential Value $173K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wilkes-Barre, PA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide BIOFIRE REAGENTS FOR TESTING COVID-19. The $438,741.54 firm-fixed-price order was placed against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. No set-aside was used. Biofire is a leader in syndromic infectious disease...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, a $126,652.50 firm-fixed-price purchase order for BioFire RP2.1 panel reagents. The contract has a completion date of February 15, 2022 and was awarded on December 3, 2020. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts from agencies such as the VA, Defense Health Agency,...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide COVID-19 testing reagents. The $223,560 firm fixed-price purchase order has a completion date of September 30, 2021. Biofire Diagnostics LLC has received numerous federal contracts to supply infectious disease testing products and services, including molecular diagnostic testing, reagents, and maintenance...
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotech company that specializes in syndromic infectious disease testing. The contract, valued at $3,679,381.66, is for the provision of reagents on a cost-per-test basis. The contract was awarded on March 23, 2017, with a completion date of August 16, 2022, and is associated with the Coronavirus COVID-19 national interest...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The $153,253.50 firm fixed-price delivery order is for reagents under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for In-Vitro Diagnostics, Reagents, and Tests. The contract is part of a larger Indefinite Delivery Contract (IDC) issued by VHA's Veterans Integrated...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $239,557.50 firm-fixed-price delivery order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide STX BIOFIRE REAGENTS for COVID-19 emergency response. This order was placed against Biofire's existing General Services Administration Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The award has a performance period ending on June 21, 2021 and does not...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract is a Blanket Purchase Agreement (BPA) call order under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a potential value of $297,026.26 and a...
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a Delivery Order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide EMERGENCY BIOFIRE FILM ARRAY diagnostic products. The $210,076.64 firm-fixed-price contract supports the Coronavirus COVID-19 National Interest Action and was issued against Biofire's existing GSA Federal Supply Schedule contract for in-vitro diagnostics. Biofire Diagnostics is a leader in syndromic infectious...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The one-year, $808,537.12 delivery order contract is for Firm Fixed Price infectious disease testing products and services, including molecular diagnostic testing, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide BIOFIRE RFIT-ASY-0124 test kits for coronavirus. The order, valued at $146,247.18, was issued against Biofire's General Services Administration Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has no set-aside designation and is for Firm Fixed Price delivery of the...